Global Small Interfering RNA (siRNA) Therapeutics Market Size, Status and Forecast 2024-2031

Report ID: 934733 | Published Date: Dec 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Liposome Based Systemic Therapy
        1.2.3 Nanoparticle Based Systemic Therapy
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Research Institutions
        1.3.4 Pharmaceutical and Biotechnology Companies
        1.3.5 Academic Institutions
        1.3.6 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Small Interfering RNA (siRNA) Therapeutics Market Perspective (2016-2027)
    2.2 Small Interfering RNA (siRNA) Therapeutics Growth Trends by Regions
        2.2.1 Small Interfering RNA (siRNA) Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Small Interfering RNA (siRNA) Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Small Interfering RNA (siRNA) Therapeutics Industry Dynamic
        2.3.1 Small Interfering RNA (siRNA) Therapeutics Market Trends
        2.3.2 Small Interfering RNA (siRNA) Therapeutics Market Drivers
        2.3.3 Small Interfering RNA (siRNA) Therapeutics Market Challenges
        2.3.4 Small Interfering RNA (siRNA) Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Small Interfering RNA (siRNA) Therapeutics Players by Revenue
        3.1.1 Global Top Small Interfering RNA (siRNA) Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Small Interfering RNA (siRNA) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Small Interfering RNA (siRNA) Therapeutics Revenue
    3.4 Global Small Interfering RNA (siRNA) Therapeutics Market Concentration Ratio
        3.4.1 Global Small Interfering RNA (siRNA) Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Small Interfering RNA (siRNA) Therapeutics Revenue in 2020
    3.5 Small Interfering RNA (siRNA) Therapeutics Key Players Head office and Area Served
    3.6 Key Players Small Interfering RNA (siRNA) Therapeutics Product Solution and Service
    3.7 Date of Enter into Small Interfering RNA (siRNA) Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Small Interfering RNA (siRNA) Therapeutics Breakdown Data by Type
    4.1 Global Small Interfering RNA (siRNA) Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Type (2022-2027)

5 Small Interfering RNA (siRNA) Therapeutics Breakdown Data by Application
    5.1 Global Small Interfering RNA (siRNA) Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size (2016-2027)
    6.2 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type
        6.2.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2027)
    6.3 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application
        6.3.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2027)
    6.4 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country
        6.4.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size (2016-2027)
    7.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type
        7.2.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application
        7.3.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country
        7.4.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size (2016-2027)
    9.2 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Type
        9.2.1 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Application
        9.3.1 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Country
        9.4.1 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 GE
        11.1.1 GE Company Details
        11.1.2 GE Business Overview
        11.1.3 GE Small Interfering RNA (siRNA) Therapeutics Introduction
        11.1.4 GE Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
        11.1.5 GE Recent Development
    11.2 Horizon Discovery
        11.2.1 Horizon Discovery Company Details
        11.2.2 Horizon Discovery Business Overview
        11.2.3 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Introduction
        11.2.4 Horizon Discovery Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
        11.2.5 Horizon Discovery Recent Development
    11.3 Thermo Scientific
        11.3.1 Thermo Scientific Company Details
        11.3.2 Thermo Scientific Business Overview
        11.3.3 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Introduction
        11.3.4 Thermo Scientific Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
        11.3.5 Thermo Scientific Recent Development
    11.4 OPKO Health
        11.4.1 OPKO Health Company Details
        11.4.2 OPKO Health Business Overview
        11.4.3 OPKO Health Small Interfering RNA (siRNA) Therapeutics Introduction
        11.4.4 OPKO Health Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
        11.4.5 OPKO Health Recent Development
    11.5 AInylam Pharmaceuticals
        11.5.1 AInylam Pharmaceuticals Company Details
        11.5.2 AInylam Pharmaceuticals Business Overview
        11.5.3 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Introduction
        11.5.4 AInylam Pharmaceuticals Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
        11.5.5 AInylam Pharmaceuticals Recent Development
    11.6 Arrowhead Research
        11.6.1 Arrowhead Research Company Details
        11.6.2 Arrowhead Research Business Overview
        11.6.3 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Introduction
        11.6.4 Arrowhead Research Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
        11.6.5 Arrowhead Research Recent Development
    11.7 Sanofi Genzyme
        11.7.1 Sanofi Genzyme Company Details
        11.7.2 Sanofi Genzyme Business Overview
        11.7.3 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Introduction
        11.7.4 Sanofi Genzyme Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
        11.7.5 Sanofi Genzyme Recent Development
    11.8 Genecon Biotechnologies
        11.8.1 Genecon Biotechnologies Company Details
        11.8.2 Genecon Biotechnologies Business Overview
        11.8.3 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Introduction
        11.8.4 Genecon Biotechnologies Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
        11.8.5 Genecon Biotechnologies Recent Development
    11.9 Arbutus Biopharma
        11.9.1 Arbutus Biopharma Company Details
        11.9.2 Arbutus Biopharma Business Overview
        11.9.3 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Introduction
        11.9.4 Arbutus Biopharma Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
        11.9.5 Arbutus Biopharma Recent Development
    11.10 Silent Therapeutics
        11.10.1 Silent Therapeutics Company Details
        11.10.2 Silent Therapeutics Business Overview
        11.10.3 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Introduction
        11.10.4 Silent Therapeutics Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
        11.10.5 Silent Therapeutics Recent Development
    11.11 Sylentis
        11.11.1 Sylentis Company Details
        11.11.2 Sylentis Business Overview
        11.11.3 Sylentis Small Interfering RNA (siRNA) Therapeutics Introduction
        11.11.4 Sylentis Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
        11.11.5 Sylentis Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Liposome Based Systemic Therapy
    Table 3. Key Players of Nanoparticle Based Systemic Therapy
    Table 4. Key Players of Other
    Table 5. Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Regions (2016-2021)
    Table 9. Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Regions (2022-2027)
    Table 11. Small Interfering RNA (siRNA) Therapeutics Market Trends
    Table 12. Small Interfering RNA (siRNA) Therapeutics Market Drivers
    Table 13. Small Interfering RNA (siRNA) Therapeutics Market Challenges
    Table 14. Small Interfering RNA (siRNA) Therapeutics Market Restraints
    Table 15. Global Small Interfering RNA (siRNA) Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Players (2016-2021)
    Table 17. Global Top Small Interfering RNA (siRNA) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Interfering RNA (siRNA) Therapeutics as of 2020)
    Table 18. Ranking of Global Top Small Interfering RNA (siRNA) Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Small Interfering RNA (siRNA) Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Small Interfering RNA (siRNA) Therapeutics Product Solution and Service
    Table 22. Date of Enter into Small Interfering RNA (siRNA) Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Type (2016-2021)
    Table 26. Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Small Interfering RNA (siRNA) Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Application (2016-2021)
    Table 30. Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. GE Company Details
    Table 63. GE Business Overview
    Table 64. GE Small Interfering RNA (siRNA) Therapeutics Product
    Table 65. GE Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
    Table 66. GE Recent Development
    Table 67. Horizon Discovery Company Details
    Table 68. Horizon Discovery Business Overview
    Table 69. Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Product
    Table 70. Horizon Discovery Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
    Table 71. Horizon Discovery Recent Development
    Table 72. Thermo Scientific Company Details
    Table 73. Thermo Scientific Business Overview
    Table 74. Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Product
    Table 75. Thermo Scientific Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
    Table 76. Thermo Scientific Recent Development
    Table 77. OPKO Health Company Details
    Table 78. OPKO Health Business Overview
    Table 79. OPKO Health Small Interfering RNA (siRNA) Therapeutics Product
    Table 80. OPKO Health Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
    Table 81. OPKO Health Recent Development
    Table 82. AInylam Pharmaceuticals Company Details
    Table 83. AInylam Pharmaceuticals Business Overview
    Table 84. AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Product
    Table 85. AInylam Pharmaceuticals Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
    Table 86. AInylam Pharmaceuticals Recent Development
    Table 87. Arrowhead Research Company Details
    Table 88. Arrowhead Research Business Overview
    Table 89. Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Product
    Table 90. Arrowhead Research Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
    Table 91. Arrowhead Research Recent Development
    Table 92. Sanofi Genzyme Company Details
    Table 93. Sanofi Genzyme Business Overview
    Table 94. Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Product
    Table 95. Sanofi Genzyme Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
    Table 96. Sanofi Genzyme Recent Development
    Table 97. Genecon Biotechnologies Company Details
    Table 98. Genecon Biotechnologies Business Overview
    Table 99. Genecon Biotechnologies Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
    Table 100. Genecon Biotechnologies Recent Development
    Table 101. Arbutus Biopharma Company Details
    Table 102. Arbutus Biopharma Business Overview
    Table 103. Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Product
    Table 104. Arbutus Biopharma Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
    Table 105. Arbutus Biopharma Recent Development
    Table 106. Silent Therapeutics Company Details
    Table 107. Silent Therapeutics Business Overview
    Table 108. Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Product
    Table 109. Silent Therapeutics Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
    Table 110. Silent Therapeutics Recent Development
    Table 111. Sylentis Company Details
    Table 112. Sylentis Business Overview
    Table 113. Sylentis Small Interfering RNA (siRNA) Therapeutics Product
    Table 114. Sylentis Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021) & (US$ Million)
    Table 115. Sylentis Recent Development
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Liposome Based Systemic Therapy Features
    Figure 3. Nanoparticle Based Systemic Therapy Features
    Figure 4. Other Features
    Figure 5. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application: 2020 VS 2027
    Figure 6. Hospital Case Studies
    Figure 7. Research Institutions Case Studies
    Figure 8. Pharmaceutical and Biotechnology Companies Case Studies
    Figure 9. Academic Institutions Case Studies
    Figure 10. Other Case Studies
    Figure 11. Small Interfering RNA (siRNA) Therapeutics Report Years Considered
    Figure 12. Global Small Interfering RNA (siRNA) Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Small Interfering RNA (siRNA) Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 15. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Regions (2022-2027)
    Figure 16. Global Small Interfering RNA (siRNA) Therapeutics Market Share by Players in 2020
    Figure 17. Global Top Small Interfering RNA (siRNA) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Interfering RNA (siRNA) Therapeutics as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Small Interfering RNA (siRNA) Therapeutics Revenue in 2020
    Figure 19. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 20. Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 21. North America Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2016-2027)
    Figure 23. North America Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2016-2027)
    Figure 24. North America Small Interfering RNA (siRNA) Therapeutics Market Share by Country (2016-2027)
    Figure 25. United States Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2016-2027)
    Figure 29. Europe Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2016-2027)
    Figure 30. Europe Small Interfering RNA (siRNA) Therapeutics Market Share by Country (2016-2027)
    Figure 31. Germany Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Market Share by Region (2016-2027)
    Figure 41. China Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2016-2027)
    Figure 49. Latin America Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2016-2027)
    Figure 50. Latin America Small Interfering RNA (siRNA) Therapeutics Market Share by Country (2016-2027)
    Figure 51. Mexico Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Small Interfering RNA (siRNA) Therapeutics Market Share by Country (2016-2027)
    Figure 57. Turkey Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Small Interfering RNA (siRNA) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. GE Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
    Figure 61. Horizon Discovery Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
    Figure 62. Thermo Scientific Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
    Figure 63. OPKO Health Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
    Figure 64. AInylam Pharmaceuticals Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
    Figure 65. Arrowhead Research Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
    Figure 66. Sanofi Genzyme Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
    Figure 67. Genecon Biotechnologies Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
    Figure 68. Arbutus Biopharma Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
    Figure 69. Silent Therapeutics Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
    Figure 70. Sylentis Revenue Growth Rate in Small Interfering RNA (siRNA) Therapeutics Business (2016-2021)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GE
Horizon Discovery
Thermo Scientific
OPKO Health
AInylam Pharmaceuticals
Arrowhead Research
Sanofi Genzyme
Genecon Biotechnologies
Arbutus Biopharma
Silent Therapeutics
Sylentis
Frequently Asked Questions
Small Interfering RNA (siRNA) Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Small Interfering RNA (siRNA) Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Small Interfering RNA (siRNA) Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Volt and VAR Systems

Volt and VAR System are the change in line voltage due to reactance elements.It is an important p ... Read More